David Zemánek

David Zemánek

Auto-generated profile, based on publicly available information

David Zemánek

Department of Cardiology, 2nd Medical School, Charles University, University Hospital Motol, Prague, Czech Republic

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 January 2014 in European Heart Journal
Verified
Journal Article
Open access
PDF file
JVJosef Veselka
Josef Veselka
JIJ. Krej i
J. Krej i
POP. Toma Ov
P. Toma Ov
DZDavid Zemánek
David Zemánek
PTPavol Tomašov
Pavol Tomašov
We decided to determine the long-term survival of patients after alcohol septal ablation (ASA) for hypertrophic obstructive cardiomyopathy (HOCM) and compare this with the general population. A total of 178 highly symptomatic, consecutive patients (58 ± 12 years, 53% women) were treated by ASA between April 1998 and April 2013 and followed-up for 4.8 years (IQR 2.1–7.5). At baseline, 155 patients (87%) suffered from dyspnoea ≥3 class of NYHA; at the most recent examination, 87 patients (49%) and 23 patients (13%) reported dyspnoea of NYHA class 1 and ≥3, respectively. The left ventricular outflow gradient was significantly reduced (68 ± 42 vs. 20 ± 25 mmHg; P < 0.01). A total of 19 deaths (11%) occurred during 925 patient-years, which means an overall mortality rate of 2.1% per year. Survival free of all-cause mortality at 1, 5, and 10 years was 97% (95% CI, 93–99%), 92% (95% CI, 87–96%), and 82% (95% CI, 70–90%), respectively. This observed mortality was comparable to the expected survival for age- and sex-comparable general population (P = 0.34). According to multivariate analysis, the only independent predictor of all-cause mortality was age at ASA (hazard ratio 1.09, 95% CI 1.04–1.14; P < 0.01). This study suggests that in patients with HOCM and important symptoms who underwent ASA, long-term survival after the procedure did not differ significantly from that of the general population.

1 January 2017 in American Heart Journal
Verified
Journal Article
Closed access
POPavel Osmancik
Pavel Osmancik
PTPetr Tousek
Petr Tousek
DHDalibor Herman
Dalibor Herman
PNPetr Neuzil
Petr Neuzil
PHPavel Hala
Pavel Hala
PWPetr Widimsky
Petr Widimsky


23 January 2009 in Heart and Vessels
Verified
Journal Article
Closed access
PDF file
JVJosef Veselka
Josef Veselka
DZDavid Zemánek
David Zemánek
PTPavol Tomašov
Pavol Tomašov
RDRadka Duchoňová
Radka Duchoňová
KLKateřina Linhartová
Kateřina Linhartová

1 September 2009 in The American Journal of Cardiology
Verified
Journal Article
Closed access
JVJosef Veselka
Josef Veselka
DZDavid Zemánek
David Zemánek
PHPetr Hájek
Petr Hájek
Martin MalyMartin Maly
Martin Maly
RARadka Adlová
Radka Adlová
DTDavid Tesař
David Tesař

1 February 2014 in International Journal of Cardiology
Verified
Journal Article
Closed access
JVJosef Veselka
Josef Veselka
JKJan Krejčí
Jan Krejčí
PTPavol Tomašov
Pavol Tomašov
VDVáclav Durdil
Václav Durdil
LRLucie Riedlbauchová
Lucie Riedlbauchová
DZDavid Zemánek
David Zemánek